>
Farmaforce logo

FFC - Farmaforce Share Price

A$0.08 0.0  0.0%

Last Trade - 1:14am

Sector
Healthcare
Size
Micro Cap
Market Cap £5.73m
Enterprise Value £5.60m
Revenue £7.57m
Position in Universe 1726th / 1908
Bullish
Bearish
Unlock FFC Revenue
Momentum
Relative Strength (%)
1m -20.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.35 1.99 3.97 7.10 11.7 14.0 +108.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020,FarmaForce Ltd revenues decreased 7% to A$5.5M. Net incometotaled A$577K vs. loss of A$2.3M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Net Income reflectsEmployee benefits expense decrease of 33% to A$820K(expense), Overhead sharing cost decrease of 93% to A$33K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

FFC Revenue Unlock FFC Revenue

Net Income

FFC Net Income Unlock FFC Revenue

Normalised EPS

FFC Normalised EPS Unlock FFC Revenue

PE Ratio Range

FFC PE Ratio Range Unlock FFC Revenue

Dividend Yield Range

FFC Dividend Yield Range Unlock FFC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FFC EPS Forecasts Unlock FFC Revenue
Profile Summary

FarmaForce Limited is engaged in the provision of services as a contract sales organization. The Company provides its pharma clients with contract sales services to general practitioners (GPs), specialists and pharmacists. The Company's services include sales teams to service both hospital and private-based specialists; sales teams to service pharmacists, including pharmacy assistants, and third-party healthcare professional relationship management. The Company operates in Australia.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated January 28, 2014
Public Since October 27, 2015
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 128,490,980
Free Float (0.0%)
Eligible for
ISAs
SIPPs
FFC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FFC
Upcoming Events for FFC
Frequently Asked Questions for Farmaforce
What is the Farmaforce share price?

As of 1:14am, shares in Farmaforce are trading at A$0.08, giving the company a market capitalisation of £5.73m. This share price information is delayed by 15 minutes.

How has the Farmaforce share price performed this year?

Shares in Farmaforce are currently trading at A$0.08 and the price has moved by 0% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Farmaforce price has moved by -25.2% over the past year.

What are the analyst and broker recommendations for Farmaforce?

There are no analysts currently covering Farmaforce.

When will Farmaforce next release its financial results?

Farmaforce is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Farmaforce dividend yield?

Farmaforce does not currently pay a dividend.

Does Farmaforce pay a dividend?

Farmaforce does not currently pay a dividend.

When does Farmaforce next pay dividends?

Farmaforce does not currently pay a dividend.

How do I buy Farmaforce shares?

To buy shares in Farmaforce you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Farmaforce?

Shares in Farmaforce are currently trading at A$0.08, giving the company a market capitalisation of £5.73m.

Where are Farmaforce shares listed? Where are Farmaforce shares listed?

Here are the trading details for Farmaforce:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: FFC
What kind of share is Farmaforce?

Based on an overall assessment of its quality, value and momentum, Farmaforce is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Farmaforce share price forecast 2021?

We were not able to load any forecast data for Farmaforce.

How can I tell whether the Farmaforce share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Farmaforce. Over the past six months, the relative strength of its shares against the market has been 1.92%. At the current price of A$0.08, shares in Farmaforce are trading at -20.3% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Farmaforce PE Ratio?

We were not able to find PE ratio data for Farmaforce.

Who are the key directors of Farmaforce?

Farmaforce's management team is headed by:

George Elias - NEC
Con Tsigounis - NED
George Syrmalis - NED
Harry Simeonidis - GMG
Terence Rego - NED
Ron Hollands - SEC
Who are the major shareholders of Farmaforce?

Here are the top five shareholders of Farmaforce based on the size of their shareholding:

iQ Group Global Ltd. Corporation
Percentage owned: 68.87% (90.0m shares)
Priority One Group Pty. Ltd. Corporation
Percentage owned: 2.12% (2.78m shares)
Elias (George) Individual Investor
Percentage owned: 1.22% (1.59m shares)
Basim Finance Pty. Ltd. Corporation
Percentage owned: 1.02% (1.33m shares)
iQ3Corp Ltd. Corporation
Percentage owned: 0.98% (1.28m shares)
Similar to FFC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.